Optional Lunch Briefing

Leveraging payer insight and healthcare data in the clinical development planning process

Monday 10th March 1.20pm – 2.30pm

Sponsored by:

• Critical clinical design requirements
• Pricing and formulary placement
• Comparative standards and analysis
• Payer market conditions for evaluation

Presenters: Bill Crown, President, i3 Innovus and Bill Broderick MS, MBA, Practice Leader, Payer & Reimbursement Strategies, i3 Innovus


Until very recently, pharmaceutical products were developed primarily on the basis of their potential clinical benefits and largely without regard to their commercialization. Over the next several years nearly $100 billion in revenue from branded drugs will evaporate as these products go generic. Clinical development programs have not been sufficiently productive to fill the void. This session will address how healthcare data, health economics and outcomes research, stakeholder input, and risk management can accelerate and improve the productivity of clinical development programs. We will also describe the evidence that is required by payers to make coverage and reimbursement decisions, as well as how this may evolve in the future

Presenters:

Bill Crown, President, i3 Innovus
William H. Crown, Ph.D., is President of i3 Innovus, the Health Economics and Outcomes Research division of Ingenix. From 1982-1995, Dr. Crown was a faculty member at the Florence Heller Graduate School, Brandeis University, where he taught graduate courses in statistics and conducted research on the economics of aging and long-term care policy. Prior to joining Ingenix in 2004, Dr. Crown was Vice President of Outcomes Research and Econometrics at Medstat, where he conducted numerous retrospective database analyses of the burden of illness associated with various diseases—particularly respiratory and mental health conditions. Dr. Crown’s work in the area of depression was one of the first applications of econometric techniques in outcomes research to control for the effects of selection bias when using retrospective data to evaluate drug technologies. He has 25 years of experience conducting health policy and income maintenance research for private-sector and public-sector clients. Dr. Crown is author or co-author of four books and more than 90 refereed journal articles, book chapters, and other publications.

Bill Broderick MS, MBA, Practice Leader, Payer & Reimbursement Strategies, i3 Innovus
William C. Broderick, MS, MBA is practice leader for the Payer and Reimbursement Strategies division of i3 Innovus and oversees business development and evidence-based consulting services for the business’ pharmaceutical manufacturer clients. Bill has more than 25 years of health care experience as a scientist, educator, hospital administrator and consultant. Prior to joining i3, Bill served as practice leader and vice president of new business development for Protocare Sciences. Bill served as vice president of outcomes management at Coram Healthcare, one of the nation's largest providers of infusion therapy and has held various executive marketing and operational positions at both the University of New Mexico Hospital and the St. Joseph Healthcare System (now Ardent) in Albuquerque, N.M. Bill has an undergraduate degree in biology from the University of Notre Dame and an M.S. in anatomy from St. Louis University, where he became doctorate-prepared in medical science. He also has an MBA in marketing and management from the University of New Mexico. Bill is a frequent national speaker on evidence-based medicine and the value of pharmaceuticals.

i3 is a global business providing integrated scientific strategies and solutions throughout the biopharmaceutical product lifecycle. Its unique combination of products, services and knowledge helps companies gain sharper insights that lead to better patient care.

www.i3global.com


« Back